SUNREST — Sunrest Lifescience Balance Sheet
0.000.00%
- IN₹229.58m
- IN₹281.02m
- IN₹294.83m
- 13
- 43
- 45
- 22
Annual balance sheet for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 3.73 | 4.8 | 4.5 | 2.9 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 74.3 | 96.9 | 117 | 192 |
Total Inventory | ||||
Total Other Current Assets | ||||
Total Current Assets | 93.2 | 125 | 163 | 248 |
Net Property, Plant And Equipment | 1.49 | 4.67 | 3.48 | 2.54 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 94.8 | 130 | 167 | 252 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 69.1 | 88.6 | 116 | 75.1 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 91.9 | 119 | 136 | 110 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 2.95 | 10.7 | 31.2 | 142 |
Total Liabilities & Shareholders' Equity | 94.8 | 130 | 167 | 252 |
Total Common Shares Outstanding |